6th RSC / SCI Ion Channels as Therapeutic Targets symposium

24 February 2020 09:00 - 25 February 2020 16:00, Cambridge, United Kingdom


Introduction
Synopsis
Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been discovered for diseases such as hypertension, epilepsy and neuropathic pain. 

This symposium, the 6th in an ongoing series, will showcase the most recent advances to aid the design of new ion channel therapeutics and promote interaction between scientists with a shared interest in the field of ion channel drug discovery.

Who should attend
Scientists from industry and academia interested in the therapeutic potential of ion channels. The organising committee particularly welcomes attendance and participation of students working in the field of ion channel research.

Features
• Medicinal chemistry case studies of ion channels as therapeutic targets
• Advances in structure determination techniques and successful structure determinations of key ion channels
• Novel pharmacology and target validation
• Emerging technologies for targeting, assaying and modulating ion channel targets
• Plenary speakers, poster sessions, trade exhibition, on-site accommodation and dinner

Call for Papers
Abstracts are invited for both oral and poster presentation, and closing dates are 21st June (oral) and 31st December 2019 (poster). Posters will be displayed throughout the meeting, there will be optional flash oral presentations, and a dedicated poster session on Monday evening.

Confirmed Speakers
Piezo1 modulation
David J Beech, University of Leeds, UK
 
Opening up new opportunities by combining high throughput electrophysiology with optical tools
Andrea Brüggemann, Nanion Technologies, Germany
 
Structural biology of ion channels
Liz Carpenter, Structural Genomics Consortium, University of Oxford, UK
 
Ion channel drug discovery - fading star or shining light?
Martin Gosling, Enterprise Therapeutics, UK
 
Discovery of small molecule scaffolds that improve stability and restore function to the F508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) anion channel
Phil Kym, AbbVie, USA
 
Please take off your coat: how naked ions ensure rapid and selective potassium channel permeation
Ulrich Zachariae, University of Dundee, UK

Registration Fees
Registration is not yet open.  Registration fees will include the conference dinner at the Wellcome Trust.

Bursaries
Discounted rates will be offered to RSC and SCI members, and some student bursaries will be available.

Exhibitors
There will be a relevant trade exhibition.  Stand space will measure 3 m  wide x 2 m deep, and include a table, chair, electrical and wi-fi access. 
The option for delegate pack inserts will also be available.

Conference Dinner
The conference dinner will be held at the Wellcome Trust and will be included in the registration fee.

Venue and Travel
Address:  Wellcome Genome Campus Conference Centre, Hinxton, Cambridge  CB10 1RQ, UK.
By air: Stansted airport is 20 minutes’ drive, London City and Luton are 60 minutes, and Heathrow and Gatwick are 90 minutes..

Accommodation
Accommodation will be available at the conference venue, and may be booked at the time of registration.  The charge will be for bed and breakfast, double or twin room for single occupancy.  Bedrooms will be available on Sunday and Monday, 23rd and 24th February (limited availability)..

Sponsors
Sponsors are encouraged to support this well-respected event
Speakers
Venue
Wellcome Genome Campus Conference Centre

Auditorium, Wellcome Genome Campus Conference Centre, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1RQ, United Kingdom

Committee
Organised by
RSC BMCS and SCI FCG
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement Spotlight Advertisement

E-mail Enquiry
*
*
*
*